Search - tctmd.com

Displaying 41 - 60 of 2279

Sort: Relevancy | Date

Presentation TCT 2025

Hertz Contact Intravascular Lithotripsy for Calcified Coronary Lesions in Real-World Practice: Primary Outcomes of the MY-IVL Study (Elixir Medical)

Presenter: Tamil Selvan Muthusamy

October 27, 2025

Presentation TCT 2025

First-in-Human Study of a Novel IVL-Based Coronary Crossing Device for Calcified Lesions (Shockwave)

Presenter: James C. Spratt

October 27, 2025

Presentation TCT 2025

TCT 1781: Iliac Catastrophe to Left-Main Salvage: Stepwise Innovation Under Absence of Crossover Sheath and In-House Surgery

Presenter: Ramachandran Sathappan

October 27, 2025

Presentation TCT 2025

A New Generation A New Generation of Laser-Based Lithotripsy for Vascular Applications (Bolt Medical): Program Update and Future Clinical Applications

Presenter: Margaret B. McEntegart

October 27, 2025

Presentation TCT 2025

Early Feasibility of the DUO™ Tricuspid Coaptation Valve System (CroiValve)

Presenter: James M. McCabe

October 27, 2025

Presentation TCT 2025

An Innovative Tricuspid Therapy: Introducing the TripairTM Technology (Coramaze)

Presenter: Paul Sorajja

October 27, 2025

Presentation TCT 2025

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

Presenter: Josep Rodés-Cabau

October 27, 2025

Presentation TCT 2025

Featured Innovation: Proactive Identification and Optimization of Structural Heart Care Using an AI-Driven Platform: Projected Use Cases from the TAILRD Heart Platform

Presenter: Jonathan Hart

October 27, 2025

Presentation TCT 2025

Trajectory Guide: A Simple Solution for CIED-Related Tricuspid Regurgitation

Presenter: Vinayak N. Bapat

October 27, 2025

Presentation TCT 2025

Will Drug-coated Balloons Change the Interventional Approach to Complex Coronary Disease?

Presenter: Margaret B. McEntegart

October 27, 2025

Presentation TCT 2025

The DragonFly T-TEER for Tricuspid Regurgitation: Technology Description and Clinical Results (Case in a Box)

Presenter: Jian'an Wang

October 27, 2025

Presentation TCT 2025

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

Presenter: Yan Wang

October 27, 2025

Presentation TCT 2025

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

Presenter: Jacob Eifer Moeller

October 27, 2025

Presentation TCT 2025

TCT 1484: CLEVE to the Rescue: Leveraging Innovation in Novel Leaflet Modification to Improve Patient Outcomes

Presenter: Dhiran Verghese

October 27, 2025

Presentation TCT 2025

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

Presenter: Xiaochun Zhang

October 27, 2025

Presentation TCT 2025

Featured Clinical Research: Pulmonary Hypertension–Based Risk Stratification for Transcatheter Tricuspid Interventions: A Harmonized, Practical Approach

Presenter: Karl-Philipp Rommel

October 27, 2025

Presentation TCT 2025

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

Presenter: Fabien Praz

October 27, 2025

Presentation TCT 2025

Transcatheter Aortic Valve Replacement with Ken-Valve™ in Aortic Regurgitation (Jenscare Scientific): 1- Year Outcomes and Large Annulus Subgroup Analysis

Presenter: Anson Cheung

October 27, 2025

Presentation TCT 2025

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

Presenter: Rasha Al-Lamee

October 27, 2025

Presentation TCT 2025

The Hanchor Valve for the Treatment of Patients with Severe Aortic Regurgitation (Hanling Medical): 1-Year Results of the Multi-Center HAVE AR Trial

Presenter: Wenzhi Pan

October 27, 2025

Advertisement

Hertz Contact Intravascular Lithotripsy for Calcified Coronary Lesions in Real-World Practice: Primary Outcomes of the MY-IVL Study (Elixir Medical)

First-in-Human Study of a Novel IVL-Based Coronary Crossing Device for Calcified Lesions (Shockwave)

TCT 1781: Iliac Catastrophe to Left-Main Salvage: Stepwise Innovation Under Absence of Crossover Sheath and In-House Surgery

A New Generation A New Generation of Laser-Based Lithotripsy for Vascular Applications (Bolt Medical): Program Update and Future Clinical Applications

Early Feasibility of the DUO™ Tricuspid Coaptation Valve System (CroiValve)

An Innovative Tricuspid Therapy: Introducing the TripairTM Technology (Coramaze)

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

Featured Innovation: Proactive Identification and Optimization of Structural Heart Care Using an AI-Driven Platform: Projected Use Cases from the TAILRD Heart Platform

Trajectory Guide: A Simple Solution for CIED-Related Tricuspid Regurgitation

Will Drug-coated Balloons Change the Interventional Approach to Complex Coronary Disease?

The DragonFly T-TEER for Tricuspid Regurgitation: Technology Description and Clinical Results (Case in a Box)

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

TCT 1484: CLEVE to the Rescue: Leveraging Innovation in Novel Leaflet Modification to Improve Patient Outcomes

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

Featured Clinical Research: Pulmonary Hypertension–Based Risk Stratification for Transcatheter Tricuspid Interventions: A Harmonized, Practical Approach

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

Transcatheter Aortic Valve Replacement with Ken-Valve™ in Aortic Regurgitation (Jenscare Scientific): 1- Year Outcomes and Large Annulus Subgroup Analysis

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

The Hanchor Valve for the Treatment of Patients with Severe Aortic Regurgitation (Hanling Medical): 1-Year Results of the Multi-Center HAVE AR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content